| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Update on Focal Therapy for Prostate Cancer
|
Ayerra Perez, Hector
|
|
|
21 |
6 |
p. 712.e1-712.e8
|
artikel
|
| 2 |
Cancer-Specific Mortality Differences in Specimen-Confined Radical Prostatectomy Patients According to Lymph Node Invasion
|
Barletta, Francesco
|
|
|
21 |
6 |
p. e461-e466.e1
|
artikel
|
| 3 |
Changes in Perception of Cure Among Patients With Genitourinary Cancers Initiating Immune Checkpoint Inhibitors: A Longitudinal Study
|
Bergerot, Cristiane Decat
|
|
|
21 |
6 |
p. 626-630.e3
|
artikel
|
| 4 |
Clinicopathologic and Survival After Cystectomy Outcomes in Squamous Cell Carcinoma of the Bladder
|
Agrawal, Pranjal
|
|
|
21 |
6 |
p. 631-638.e1
|
artikel
|
| 5 |
Cost-effectiveness of Nivolumab Plus Cabozantinib Versus Cabozantinib as First-Line Treatment of Metastatic Renal Cell Carcinoma
|
Liu, Tong
|
|
|
21 |
6 |
p. e449-e460
|
artikel
|
| 6 |
Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?
|
Andruska, Neal
|
|
|
21 |
6 |
p. 653-659.e1
|
artikel
|
| 7 |
Does the Gleason Score 7 Upgrading Always Predict Worse Prognosis?
|
Zhou, Jiatong
|
|
|
21 |
6 |
p. e412-e421
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
21 |
6 |
p. A1
|
artikel
|
| 9 |
Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research
|
Ebrahimi, Hedyeh
|
|
|
21 |
6 |
p. e467-e473
|
artikel
|
| 10 |
Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG—AFU 26 NIVOREN
|
Guilhem-Ducléon, Guillemette
|
|
|
21 |
6 |
p. 643-652
|
artikel
|
| 11 |
Impairment in Activities of Daily Living Assessed by the Barthel Index Predicts Adverse Oncological Outcomes After Radical Cystectomy for Bladder Cancer
|
Panunzio, Andrea
|
|
|
21 |
6 |
p. e495-e501.e2
|
artikel
|
| 12 |
Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy Study
|
Ghali, Fady
|
|
|
21 |
6 |
p. 669-678
|
artikel
|
| 13 |
Modified GLIM Status as a Predictor of Morbidity and Mortality After Radical Cystectomy: A Propensity Matched Analysis
|
Abou Chawareb, Elia
|
|
|
21 |
6 |
p. 710.e1-710.e8
|
artikel
|
| 14 |
Novel Approaches in the Systemic Management of High-Risk Prostate Cancer
|
Gómez-Aparicio, Maria Antonia
|
|
|
21 |
6 |
p. e485-e494
|
artikel
|
| 15 |
Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis
|
Hakimi, Kevin
|
|
|
21 |
6 |
p. 694-702
|
artikel
|
| 16 |
Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy
|
Urman, Danielle
|
|
|
21 |
6 |
p. 660-668.e1
|
artikel
|
| 17 |
Perivesical Fat Invasive Pattern as Prognostic Factor and Predictor of Response to Adjuvant Chemotherapy in T3 Stage Bladder Cancer
|
Lu, Jiangli
|
|
|
21 |
6 |
p. e422-e428
|
artikel
|
| 18 |
Pretreatment Lymphocyte to C-Reactive Protein Ratio: An Independent Predictor of Overall Survival in Metastatic Hormone-Naïve Prostate Cancer Patients
|
Sasaki, Takeshi
|
|
|
21 |
6 |
p. e474-e484
|
artikel
|
| 19 |
Prostate-specific antigen level association with COVID-19 infection and vaccination
|
Frumer, Michael
|
|
|
21 |
6 |
p. e405-e411
|
artikel
|
| 20 |
Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus Nivolumab
|
McManus, Hannah D.
|
|
|
21 |
6 |
p. e429-e437.e2
|
artikel
|
| 21 |
Survival After Cryotherapy Versus Radiotherapy in Low and Intermediate Risk Localized Prostate Cancer
|
Li, Han
|
|
|
21 |
6 |
p. 679-693
|
artikel
|
| 22 |
Table of contents
|
|
|
|
21 |
6 |
p. A3-A7
|
artikel
|
| 23 |
Targeted Biopsy in Men High Risk for Prostate Cancer: 68Ga-PSMA PET/CT Versus mpMRI
|
Pepe, Pietro
|
|
|
21 |
6 |
p. 639-642
|
artikel
|
| 24 |
The Impact of Blue Light Cystoscopy Use Among Nonmuscle Invasive Bladder Cancer Patients in an Equal Access Setting: Implications on Recurrence and Time to Recurrence
|
Das, Sanjay
|
|
|
21 |
6 |
p. 711.e1-711.e6
|
artikel
|
| 25 |
The Risk of Catastrophic Healthcare Expenditures Among Prostate and Bladder Cancer Survivors in the United States
|
Stone, Benjamin V.
|
|
|
21 |
6 |
p. 617-625
|
artikel
|
| 26 |
Treatment Patterns and Efficacy of Chemotherapy After Pembrolizumab in Advanced Urothelial Cancer-a Real-World Study in the pre-Antibody-Drug Conjugate Era
|
Holmsten, Karin
|
|
|
21 |
6 |
p. e438-e448
|
artikel
|
| 27 |
Trends of Lymph Node Outcomes in Partial Cystectomy for Muscle-Invasive Urothelial Carcinoma of the Bladder
|
Klose, Charles
|
|
|
21 |
6 |
p. 703-709
|
artikel
|
Tijdschrift beschrijving